Publications by authors named "Matthias Groschek"

Claim this Profile
I
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010).
Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Ingeborg Roetzer, Wolfgang Blau, Thomas Zander, Matthias Groschek

Clin Nutr ESPEN· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Christian Geßner, Thomas Fietz, Christoph Losem, Andreas Lück, Holger Schulz, Matthias Groschek

Curr Med Res Opin· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.
Tobias Dechow, Ali Aldaoud, Timo Behlendorf, Wolfgang Knauf, Henning Eschenburg, Matthias Groschek

Eur J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Martin Sebastian, Wilfried E E Eberhardt, Petra Hoffknecht, Martin Metzenmacher, Thomas Wehler, Matthias Groschek

Lung Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Salah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, Claudia Pauligk, Caroline Schönherr, Matthias Groschek

Int J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Anja Welt, Marcel Wiesweg, Sarah Theurer, Wolfgang Abenhardt, Matthias Groschek

Cancer Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial].
C Benedikt Westphalen, Volker Heinemann, Hans Werner Tessen, Matthias Groschek, Heinz-Gert Hoeffkes

Z Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

Ann Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.
Norbert Gattermann, Andrea Jarisch, Rudolf Schlag, Klaus Blumenstengel, Mariele Goebeler, Matthias Groschek

Eur J Haematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis